Exact Sciences Corporation
Innovation One, the headquarters of Exact Sciences in Madison, Wisconsin (2020). | |
| Type | Subsidiary |
|---|---|
| Nasdaq: EXAS | |
| Industry | Molecular diagnostics |
| Founded | 1995 in Marlborough, Massachusetts |
| Founders |
|
| Headquarters | Madison, Wisconsin, U.S. |
| Key people | |
| Products | Cologuard, Oncotype DX, Oncotype MAP |
| Revenue | |
| Total assets | |
| Total equity | |
Number of employees | 6,500 (Dec 2023) |
| Parent | Abbott Laboratories |
| Subsidiaries | Subsidiary List
|
| Website | exactsciences |
| Footnotes | |
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
In November 2025, Abbott Laboratories announced an agreement to acquire Exact Sciences in a deal worth roughly $21 billion.